06 mar: Rovsing A/S – optagelse til handel og officiel notering af nye ak..
06 mar: Aktietilbagekøbsprogram på DKK 400 mio. igangsættes
06-03-2019 13:04:16

Annual Report 2018

Company Announcement No. 8/2019 — 6 March 2019

Annual Report 2018

Royal Unibrew achieved the best results ever due to strong execution boosted by a historically warm summer in 2018

  • Total net revenue increase of 14%
  • Solid organic improvement of topline (9%) and topline improvement from acquisitions (5%)
  • Royal Unibrew generally increased its market shares in 2018
  • EBITDA-margin and EBIT-margin increased
  • Earnings per share up from DKK 16.0 to DKK 20.6 (+29%)
  • Expected distribution to shareholders of DKK 950 million (2017: DKK 870 million) allocated on:
    • Dividend of DKK 10.80 per share (2017: DKK 8.90)
    • New share buy-back program of DKK 400 million (2017: DKK 400 million)
  • Three acquisitions completed
  • Royal Unibrew maintains its strategic flexibility

“During 2018, Royal Unibrew continued to see good momentum in the business delivering a solid development in both net revenue and earnings – and we achieved our best results ever. Our performance is attributable to a solid organic development across markets, the acquisitions carried out in the course of the past year as well as a historically warm summer in Northern Europe. Noting the foundation of our earnings improvement and considering our future earnings potential, we increase our EBIT-margin target from about 17% to a 18-19% range. At the same time, we launch a share buy-back program for 2019 of up to DKK 400 million and propose a distribution of ordinary dividend of DKK 10.80 per share, corresponding to a 21% increase on 2017. With this distribution of a total of DKK 950 million we maintain our strategic flexibility”, says Hans Savonije, President & CEO.  

Selected Financial Highlights and Ratios

   Q1-Q4

Q4

MDKK

 

2018

2017

 

2018

2017

Volumes (thousand hectolitres) 10,8059,912 2,4042,313
Net revenue 7,2986,384 1,6741,516
EBITDA 1,6731,362 331286
EBITDA-margin (%) 22.921.3 19.718.9
Earnings before interest and tax (EBIT) 1,3391,069 248208
EBIT-margin (%) 18.416.7 14.813.7
Profit before tax 1,3281,056 247203
Net profit for the year 1,040831 188163
Free cash flow 942950 -92239
 

 

      

MDKK

 

Q4 2018

Q4 2017

Q4 2016

Q4 2015

 
Net interesting-bearing debt 2,5229759911,184 
NIBD/EBITDA (current 12 months) 1.50.70.81.0 
Equity ratio (%) 36424843 

Outlook for 2019

      
  

Outlook

Actual

Actual

 

MDKK

 

2019

2018

2017

 
Net revenue 7,400-7,6507,2986,384 
EBIT 1,340-1,4651,3391,069 
      

The Annual Report 2018 has been published via Nasdaq Copenhagen A/S and is enclosed with this announcement.

The Annual Report 2018 is also available on www.royalunibrew.com.

For further information on this announcement:

Hans Savonije, President & CEO, tel. +45 22 20 80 17.

It will be possible for investors and analysts to follow Royal Unibrew’s presentation of the Annual Report 2018 on Thursday, 7 March 2019, at 9 am (CET) by audiocast at one of the below dial-in numbers followed by the confirmation code.

Denmark:  +45 32 72 80 42

United Kingdom:  +44 (0) 2071 928000

United States of America:  +163 151 074 95

Confirmation code: 2729049

Financial Calendar 2019

25 April 2019              Interim Report for the period 1 January — 31 March 2019

25 April 2019              Annual General Meeting at Odense Congress Center in Odense

27 August 2019          Interim Report for the period 1 January — 30 June 2019

13 November 2019    Interim Report for the period 1 January — 30 September 2019  

Disclaimer

This announcement contains forward-looking statements, including statements about the Group's sales, revenues, earnings, spending, margins, cash flow, inventory, products, actions, plans, strategies, objectives and guidance with respect to the Group's future operating results. Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate or imply future results, performance or achievements, and may contain the following words or phrases "believe, anticipate, expect, estimate, intend, plan, project, will be, will continue, likely to result, could, may, might", or any variations of such words or other words with similar meanings. Any such statements involve known and unknown risks, estimates, assumptions and uncertainties that could cause the Group's actual results, performance, or industry results to differ materially from the results expressed or implied in such forward-looking statements. The Group assumes no obligation to update any such forward-looking statements to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking statements.

Some important risk factors that may have direct bearing on the Group's actual results include, but are not limited to: economic and political uncertainty (including interest rates and exchange rates), financial and regulatory developments, development in the demand for the Group's products, introduction of and demand for new products, the competitive environment and the industry in which the Group operates, changes in consumer preferences, increasing industry consolidation, the availability and pricing of raw materials and packaging materials, cost of energy, production- and distribution-related issues, information technology failures, breach or unexpected termination of contracts, price reductions resulting from market-driven price reductions, determination of fair value in the opening balance sheet of acquired entities, litigation, environmental issues and other unforeseen factors.

New risk factors can emerge in the future, which the Group cannot predict. Furthermore, the Group cannot assess the impact of each factor on the Group's business or the extent to which any individual risk factor, or combination of factors, may cause results to differ materially from those contained in any forward-looking statement. Accordingly, forward-looking statements should not be relied on as a prediction of actual results.

The Annual Report 2018 has been prepared in English. An excerpt of the Annual Report 2018 in Danish is available on www.royalunibrew.com. In case of discrepancy the Annual Report 2018 shall prevail.

 

Attachment

Relateret indhold
09 apr - 
Aktier/middag: Lille løft i afventende nyhedsfattigt ma..
28 mar - 
Torsdagens aktier: Demant endte i bunden af C25 - Santa..
28 mar - 
Aktier/middag: Demant er dagens bundskraber - Unibrew s..
Relateret debat
19:23 - 
Ja jeg skulle have valgt den frem for Harboe, men måske..
18 apr - 
Dt har været en fantastisk aktie med mere end 5000 % si..
17 apr - 
Til gengæld steg Harboe 2,8% idag og var oppe med over ..
Del

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
16 apr
RBREW
Det ser ud som om der ikke er mere gas i den ballon. Kursen er tilbage på juni 2018 niveau og efter ..
1

Fondsbørsmeddelelser

Episode 15 - Lars Seier Christensen ser FC Porto som model for FCK

11-04-2019 15:15:13
I denne episode er finansmanden Lars Seier Christensen gæst i studiet hos Euroinvestors Lars Christensen til en snak om investeringer i sports- og fritidsindustrien med afsæt i Lars Seier Christensens nylige investering i Parken Sport & Entertainment - virksomheden bag fodboldklubben FC København.I samtalen fremhæver Lars Seier Christensen blandt andet den portugisiske fodklub FC Porto som en mode..

Aktier/tendens: Panalpina-tal kan give DSV-fokus i rolig handelsstart

17-04-2019 07:48:02
DSV kan komme i fokus onsdag, efter at schweiziske Panalpina, som den danske transportgigant er ved at overtage, fra morgenstunden har præsenteret regnskabstal, der var bedre end ventet blandt analytikerne.I årets første kvartal nåede Panalpina en omsætning på 1,49 mia. schweizerfranc, svarende til 9,8 mia. kr., hvor der blandt analytikere adspurgt af Bloomberg News var ventet en omsætning på 1,45..

Genmab-partner leverer bedre end ventet: Darzalex skuffer lidt

16-04-2019 12:58:48
Den amerikanske medicinalvirksomhed Johnson & Johnson, der samarbejder med danske Genmab omkring salg af kræftmidlet Darzalex, har leveret et bedre end ventet regnskab for første kvartal.Til gengæld ser det globale salg af Darzalex ud til at skuffe, da det i første kvartal endte på 629 mio. dollar. Til sammenligning havde Sydbanks senioranalytiker Søren Løntoft Hansen ventet et globalt salg på 660..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge

Relaterede aktiekurser

Royal Unibrew A/S 473.10 -2,1% Fald i aktiekurs

Copyright Berlingske Media 2019  Handelsbetingelser  |  Cookiedeklaration  |  Cookie- og Privatlivspolitik  |  Ophavsret og vilkår
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
19. april 2019 20:22:53
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20190410.2 - EUROWEB4 - 2019-04-19 20:22:53 - 2019-04-19 20:22:53 - 1 - Website: OKAY